Sign inJoin waitlistJoin the waitlist

Francine Foss

Associate Program Director · Yale-New Haven Hospital

Credentials: · · · · ·

History

Yale-New Haven Hospital
Present
T CELL Forum
Present
Yale-New Haven Hospital · Yale School of Medicine
Present

National Cancer Institute
1983–1985
The Medical Center
1982–1985
Internal Medicine
Brigham and Women's Hospital
1980–1983
University of Massachusetts Medical School
1978–1982
Dartmouth College
1974–1978

Research

Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma
Journal of Clinical Oncology · 2007 · 833 citations
Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy
Journal of Clinical Oncology · 2012 · 564 citations
Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma
Journal of Clinical Oncology · 2001 · 468 citations

SH
Steven Horwitz
36 papers
Michael Girardi
32 papers
MD
Madeleine Duvic
22 papers
Timothy Kuzel
20 papers
AS
Andrei Shustov
18 papers
Barbara Pro
18 papers
Stuart Seropian
18 papers
Iris Isufi
17 papers
LP
Lauren Pinter-Brown
17 papers
YK
Youn-Hee Kim
17 papers
LS
Lubomir Sokol
16 papers
KC
Kacie Carlson
14 papers

Clinical trials

Study Of Intratumoral G100 In Cutaneous T Cell Lymphoma
Principal investigator · Withdrawn · Phase 2
Yale University
2019–2022
Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.
Principal investigator · Recruiting
Associazione Angela Serra per la ricerca sul cancro
2018–2025
An Open Label, International, Multi-centre, Phase I/IIa Study of Lenalidomide (Revlimid) and Romidepsin (Istodax) for Relapsed /Refractory Hodgkin Lymphoma, Mature T-cell Lymphoma and Multiple Myeloma. (RId Study)
Principal investigator · Terminated · Phase 1
Yale University
2012–2016
A Pilot Study of Sorafenib Examining Biomarkers in Refractory or Relapsed T-Cell Lymphoma Patients
Principal investigator · Completed · Phase 1
Yale University
2009–2013